Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1210/jendso/bvaa149 http://scihub22266oqcxt.onion/10.1210/jendso/bvaa149 33173841!7641317!33173841     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Endocr+Soc 2020 ; 4 (12): bvaa149 Nephropedia Template TP {{tp|p=33173841|t=2020. Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus |pdf=|usr=}}{{33173841}} gab.com Text Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus JO: J Endocr Soc http://www.kidney.de/pget.php?&tw=1&pmid=33173841 #FOAvip AIM: To examine the impact of the lockdown caused by the COVID-19 pandemic on both the glycemic control and the daily habits of a group of patients with type 1 diabetes mellitus (T1DM) using flash continuous glucose monitoring devices (flash CGMs). METHODS: Retrospective analysis based on all the information gathered in virtual consultations from a cohort of 50 adult patients with T1DM with follow-up at our site. We compared their CGM metrics during lockdown with their own previous data before the pandemic occurred, as well as the potential psychological and therapeutic changes. RESULTS: We observed a reduction of average glucose values: 160.26 +/- 22.55 mg/dL vs 150 +/- 20.96 mg/dL, P = .0009; estimated glycosylated hemoglobin: 7.21 +/- 0.78% vs 6.83 +/- 0.71%, P = .0005; glucose management indicator 7.15 +/- 0.57% vs 6.88 +/- 0.49%; P = .0003, and glycemic variability: 40.74 +/- 6.66 vs 36.43 +/- 6.09 P < .0001. Time in range showed an improvement: 57.46 +/- 11.85% vs a 65.76 +/- 12.09%, P < .0001, without an increase in percentage of time in hypoglycemia. CONCLUSIONS: COVID-19 lockdown was associated with an improvement in glycemic control in patients with T1DM using CGMs. Twit Text FOAVip Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus ????J Endocr Soc http://www.kidney.de/pget.php?&tw=1&pmid=33173841 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33173841 #FOAvip English Wikipedia <ref>{{Cite pmid|33173841}}</ref> Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus #MMPMID33173841 Pla B; Arranz A; Knott C; Sampedro M; Jimenez S; Hernando I; Marazuela M J Endocr Soc 2020[Dec]; 4 (12): bvaa149 PMID33173841show ga AIM: To examine the impact of the lockdown caused by the COVID-19 pandemic on both the glycemic control and the daily habits of a group of patients with type 1 diabetes mellitus (T1DM) using flash continuous glucose monitoring devices (flash CGMs). METHODS: Retrospective analysis based on all the information gathered in virtual consultations from a cohort of 50 adult patients with T1DM with follow-up at our site. We compared their CGM metrics during lockdown with their own previous data before the pandemic occurred, as well as the potential psychological and therapeutic changes. RESULTS: We observed a reduction of average glucose values: 160.26 +/- 22.55 mg/dL vs 150 +/- 20.96 mg/dL, P = .0009; estimated glycosylated hemoglobin: 7.21 +/- 0.78% vs 6.83 +/- 0.71%, P = .0005; glucose management indicator 7.15 +/- 0.57% vs 6.88 +/- 0.49%; P = .0003, and glycemic variability: 40.74 +/- 6.66 vs 36.43 +/- 6.09 P < .0001. Time in range showed an improvement: 57.46 +/- 11.85% vs a 65.76 +/- 12.09%, P < .0001, without an increase in percentage of time in hypoglycemia. CONCLUSIONS: COVID-19 lockdown was associated with an improvement in glycemic control in patients with T1DM using CGMs. äImpact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 (epmc).pdf DeepDyve Pubget Overpricing